The function of CD44-v3 and heparin/heparan sulfate (HS) signaling was investigated during trophoblast cell migration to identify their role in the renewal of syncytial layer damage caused by increased hemodynamic turbulence in the intervillous space and maintenance of syncytial integrity in pre-eclampsia. We evaluated the effect of heparin/HS/CD44-v3-mediated processes during scratch wound closure in monolayer immortalized human trophoblast cells derived from term placenta (TCL-1 cells). Western blot analysis showed that these cultured human trophoblast cells express the epidermal growth factor receptor and CD44-v3 but do not express syndecan 4. An in vitro scratch wound healing assay showed enhanced migration of trophoblast cells in a dose-dependent manner in the presence of heparin compared with controls when cultured under serumfree conditions. Conversely, an anti-CD44 function-blocking antibody and CD44 siRNA suppressed the migration of trophoblast cells in the presence of heparin in a similar scratch assay. Furthermore, both heparin treatment and in vitro scratch wounding induced the phosphorylation of p21-activated kinase 1 (PAK1), whereas the anti-CD44-v3 antibody suppressed the heparin-induced phosphorylation of PAK1 in trophoblast cells. These results indicate that heparin/HS/CD44-v3-mediated signaling, in the absence of growth factor networks, enhances the direct repair of the damaged trophoblast layer through the migration of trophoblast cells. This renewed cell coverage may lead to the maintenance of syncytiotrophoblast cell function and an associated reduction in pathogenic soluble factors derived from the damaged trophoblast cells.
INTRODUCTION
Pre-eclampsia (PE) is a multiorgan complication of pregnancy characterized by high blood pressure and proteinuria. It occurs in 2%-5% of all pregnancies and is a major cause of maternal and fetal morbidity and mortality [1] . Although the etiology of PE remains unclear, impaired trophoblastic invasion into the inner myometrial portion of the spiral arteries causes them to retain their musculoelastic properties [2] , resulting in hypoperfusion [3] , hypoxia [4] , and subsequently, excess production of soluble fms-like tyrosine kinase 1 (sFLT1) by trophoblast cells. This up-regulation of sFLT1 promotes an antiangiogenic state within the intervillous space [5] . Furthermore, hypoperfusion and hypoxia are also responsive to vasoactive substances, which results in vasospasm and vasoconstriction of the uterine artery [6] . These vascular responses can, secondarily, lead to the activation of the coagulation system in the intervillous space and induce further ischemic damage to the trophoblast cells. Given the slow placental blood flow within the intervillous space compared with the fast arterial flow, vasoconstriction of the uterine arteries likely enhances eddy currents and stasis, which can activate blood platelets; the accompanying membranous changes induce a hypercoagulable state [7, 8] . A recent study has shown that uteroplacental hemodynamic alterations, which result in increased turbulence in the intervillous flow, have the potential to influence both the integrity of the syncytiotrophoblast and the release of potentially pathogenic soluble factors [9] . That study also suggested the damaged trophoblast undergoes a natural cycle of cell turnover to renew and maintain the syncytial layer within the villous placenta.
Heparin is a glycosaminoglycan composed of sulfated oligosaccharides with polymeric units of varying lengths combined with a specialized form of heparan sulfate (HS) synthesized exclusively by connective tissue mast cells, whereas HS is produced by many cell types. Heparin has been clinically used to prevent pregnancy loss due to complications arising from prothrombotic disorders, such as antiphospholipid syndrome (APS), that are caused by anticoagulation [10] . Recent studies have shown that heparin exerts various biological effects, including the prevention of programmed trophoblast cell death [11] , enhanced cellular invasion of first-trimester extravillous trophoblast (EVT) [12] , and conversely, the suppressed invasion of EVT [13] . On the cell surface, HS proteoglycan (HSPG) has been shown to bind to syndecan [14] and CD44-v3 within a growth factor network [15] , where it acts as a coreceptor [16] to induce signaling within cells through growth factor receptors or CD44 itself; this results in the induction of cell migration and various other biological effects. Growth factor interactions, such as with heparin-binding epidermal growth factor (EGF) and fibroblast growth factor (FGF), are mediated by the negatively charged sulfate groups found on HS.
CD44 is a multifunctional cell surface receptor of the hyaladherin or link protein superfamily of adhesion molecules and is expressed as the standard form (CD44s) or as one of 12 distinct isoforms (CD44-v1 to CD44-v12) [17, 18] . HS interacts with the membrane-proximal extracellular domain of CD44-v3 [19] . In human placenta, immunohistochemical localization of CD44 and the binding protein hyaluronan have suggested that CD44 may be important in tissue remodeling later during gestation, whereas hyaluronan likely is involved in early villous morphogenesis [20] . The reduction in CD44-v6 expression from first-trimester villi to term placenta indicates that CD44 splicing variants might play a role in the invasion of trophoblast cells into maternal tissue during early pregnancy [21] . However, the function of heparin/HSPG/CD44-v3-mediated migration of trophoblast cells at the site of tissue injury and its potential role in the maintenance of the syncytial layer have yet to be determined.
In the present study, we examined the ability of migrating trophoblast cells to restore the integrity of scratched monolayer trophoblasts (immortalized human trophoblast cell lines derived from term placenta) [22] to investigate whether damage to the syncytial layer, caused by hemodynamic turbulence in the intervillous space, could be repaired with heparin/HSPG/CD44-v3-mediated processes.
MATERIALS AND METHODS

Antibodies
A rabbit polyclonal anti-cytokeratin 7 antibody was purchased from Acris Antibodies GmbH. Rabbit polyclonal anti-CD9 and anti-CD44 antibodies were purchased from Abcam. A rabbit polyclonal anti-EGF-receptor antibody and an anti-syndecan 4 (H-140) receptor antibody were purchased from Santa Cruz Biotechnology, Inc. Rabbit polyclonal anti-CD44-v3 antibody was purchased from Millipore. The rabbit polyclonal anti-FGF-receptor 4, p21-activated kinase 1 (PAK1), phospho-PAK1 (Thr423), and phospho-PAK1 (Ser199/204) antibodies were purchased from Cell Signaling Technology.
Collection of Normal Placental Tissue
Normal term placental tissue, used to obtain normal control trophoblast cells, was acquired at an uncomplicated elective cesarean section; the procedure was performed due to a previous cesarean section. A 1-cm 3 block of tissue was taken from deeper in the placental cotyledon, which contains only villous tissue. Each sample was checked by histology. The present study was approved by the ethics committee of Juntendo University School of Medicine, and informed consent for taking normal term placental tissue at delivery was obtained from each patient at the outpatient clinic.
Cell Culture
Term placenta-derived immortalized Trophoblast Cell Line-1 (TCL-1) cells at the 20th passage were a gift from Saitama Medical Center (Saitama Prefecture, Japan). TCL-1 cells were cultured in RPMI-1640 medium supplemented with 10% fetal bovine serum (FBS; Invitrogen), 50 U/ml of penicillin G (Invitrogen), and 50 lg/ml of streptomycin (Invitrogen). The cultures were maintained at 378C in a humidified atmosphere consisting of 95% air and 5% CO 2 .
In Vitro Scratch Assay
After reaching confluence, TCL-1 cells grown in six-well culture plates (AGC Techno Glass Co., Ltd.) were starved in serum-free conditions for 24 h, and then scratch wounds were made as described previously [23] . Briefly, a sterile, 200-ll pipette tip was used to make a scratch wound by streaking it across the monolayer of TCL-1 cells. Multiple photographs were taken of the wound, and the blank areas containing no cells were measured with imageanalysis software (KS400; Carl Zeiss Imaging GmbH) at 0, 24, 48, and 72 h in the presence or absence of heparin at a final concentration of 1000 U/ml. The percentage of the whole wound area that was newly covered with cells was measured to evaluate migration. To examine the effect of CD44 inhibition on cell migration in the presence of heparin, cells treated with either a polyclonal anti-CD44 function-blocking antibody or nonimmune rabbit immunoglobulin (Ig) G (used at a final concentration of 0.2 lg/ml) were starved for 24 h in serum-free media, then scratched and maintained in the presence or absence of heparin. The percentage wound closure at 72 h after scratching was calculated. Furthermore, the effect of the phosphoinositol 3-kinase (PI3K) inhibitor KY12420 (used at a final concentration of 4 nM; Cell Signaling Technology Japan, K.K.) on heparin-enhanced cell migration was examined 48 h after scratch wounding.
Western Blot Analysis
Normal term placental tissues (n ¼ 5) were harvested and homogenized in lysis buffer (CelLytic MT; Sigma-Aldrich., Inc.) containing Protease Inhibitor Cocktail (Sigma-Aldrich, Inc.) and used as a control for TCL-1 cells to examine the expression of heparin binding-related cell surface receptors and trophoblast cell-related proteins.
Confluent TCL-1 cells were starved for 24 h before a scratch wound was made. To examine the phosphorylation state of PAK1 in TCL-1 cells, cells were harvested and homogenized 15, 30, or 60 min after the addition of heparin and/or scratch wounding. To identify if heparin-induced PAK1 signaling is mediated through CD44-v3, cells were incubated in the presence of the anti-CD44-v3 antibody for 45 min; the cells were then harvested and homogenized 15, 30, or 60 min after the addition of heparin. Expression of beta-actin was used as a loading control.
After centrifugation at 20 000 3 g for 10 min at 48C, the protein concentration of the supernatant was determined using a BCA (bicinchoninic acid) Protein Assay (Pierce). Ten micrograms of each protein sample were used for Western blot analysis. Proteins were separated by SDS-PAGE and transferred to polyvinylidene fluoride membranes (Immobilon P; Millipore). The membranes were blocked with 1% bovine serum albumin in Tris-buffered saline with 0.05% Tween-20 for 1 h and subsequently incubated overnight at 48C with specific antibodies for detection of CD44, CD44-v3, syndecan 4, cytokeratin 7, CD9, beta-actin, EGF receptor, FGF receptor, PAK1, and phosphorylated PAK1. The membranes were washed and then incubated in appropriate horseradish peroxidase-conjugated secondary antibodies, and immunoreactivity was detected using the ECL Plus detection kit (GE Healthcare) according to the manufacturer's instructions. Semiquantitative densitometric analysis of the immunoreactive bands (intensity 3 area) was performed using MultiGauge software (Fujifilm).
Small Interfering RNA Oligos and Transfections
To investigate the function of CD44 during cell migration, an siRNA sequence targeting human CD44 was generated using mRNA sequences from Invitrogen. A CD44 target sequence ( The efficiency of siRNA-mediated gene silencing was assessed by Western blot analysis 52 h after transfection with specific or scrambled siRNA.
Statistical Analysis
Data are presented as the mean 6 SD of representative independent experiments (n ¼ 3) unless otherwise specified. Percentage wound closure in the in vitro scratch assays was analyzed using Student t-test. Changes in wound closure and phosphorylation of PAK1 were analyzed using repeated-measures ANOVA. All analyses were performed using StatView software (Abacus Concepts), and P , 0.05 was considered to be significant.
RESULTS
Characterization of TCL-1 Cells
To evaluate whether TCL-1 cells retain the characteristics of term placenta-derived trophoblast cells, the expression of cytokeratin 7 and CD9 was examined in both cell types. As shown in Figure 1 , Western blot analysis positively identified the expression of cytokeratin 7 and CD9 in TCL-1 cells. TCL-1 cells also expressed CD44, CD44-v3, the FGF receptor, and the EGF receptor, although no immunoreactivity was observed for syndecan 4, which is expressed by normal term placental trophoblast cells. Densitometric analysis showed the expression of CD44-v3 and CD44 in TCL-1 cells was similar to that in trophoblast cells from term placental tissue.
Unfractionated Heparin Enhances Migration in Scratched TCL-1 Cells
The effect of unfractionated heparin on the migration of TCL-1 cells in monolayer wound healing was examined with SUGA ET AL.
an in vitro scratch assay (Fig. 2a) . Wound closure was significantly enhanced in TCL-1 cells in the presence of heparin compared to heparin-free conditions (Fig. 2b) . Wound closure in the presence of various concentrations of heparin (100-1000 U/ml) showed a significant dose-dependent response, with the greatest enhancement of closure observed at a final heparin concentration of 1000 U/ml. Low-molecularweight heparin also significantly enhanced wound closure.
Anti-CD44 Function-Blocking Antibody Inhibits HeparinEnhanced Wound Closure in TCL-1 Cells
To evaluate the function of CD44 on heparin-enhanced TCL-1 cell migration in monolayer wound healing, the inhibitory effects of an anti-CD44 function-blocking antibody were examined with an in vitro scratch assay. In the presence of a polyclonal anti-CD44 function-blocking antibody, scratch wound closure under serum-free conditions was significantly inhibited compared with controls (Fig. 3) .
CD44 siRNA Inhibits Heparin-Enhanced Wound Closure in TCL-1 Cells
To evaluate the function of CD44 during heparin-enhanced TCL-1 cell migration in monolayer wound healing, an in vitro scratch assay was used to examine the effect of CD44 siRNA on wound closure. As described in Materials and Methods, 52 h after incubation with CD44 siRNA and subsequent starvation for 24 h, a scratch wound was made under serum-free conditions (designated as the 0-h time point in Fig. 4a ). Scratch wound closure was significantly inhibited in CD44 siRNA transfected cells compared to those cells transfected with scrambled siRNA at 24, 48, and 72 h after scratch wounding. Moreover, basal cell migration was similarly reduced in cells transfected with CD44 siRNA in the presence or absence of heparin compared to transfection with scrambled siRNA (Fig. 4a) . Furthermore, Western blot analysis showed that the constitutive expression of CD44 in TCL-1 cells was maintained 76 h after transfection with scrambled siRNA. However, the expression of CD44 in CD44 siRNA-transfected cells was inhibited 76 h after transfection, and this reduced 
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expression remained detectable after an additional 72 h (Fig.  4b) .
Scratch Wounding and/or Unfractionated Heparin Induces Phosphorylation of PAK1 in TCL-1 Cells
It has been shown previously that PAK1 plays important roles in cell motility and migration [24] . To determine if the effect of heparin treatment and/or scratch wounding on TCL-1 cells is mediated by the induction of PAK1 phosphorylation, Western blot analysis was used to examine the phosphorylation state of PAK1 at 15, 30, or 60 min after the addition of heparin and/or scratch wounding (Fig. 5) . Western blot analysis identified that the ratio of phosphorylated PAK1 to unphosphorylated PAK1 at Ser199/204 and Thr423 showed a gradual, significant increase following heparin treatment, with maximum PAK1 phosphorylation levels observed 60 min after the addition of heparin (Fig. 5a ). In contrast, the ratio after scratch wounding showed a rapid increase, with maximum levels observed 15 min after the scratch wound was made; thereafter, the levels showed a gradual, significant decrease (Fig. 5b) . The levels of PAK1 phosphorylation at Ser199/204 and Thr423 in TCL-1 cells exposed to both heparin and scratch wounding were significantly increased, and maximum levels of phosphorylation were observed 60 min after treatment (Fig. 5c) . 
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Anti-CD44v3 Function-Blocking Antibody Inhibits HeparinInduced Phosphorylation of PAK1 in TCL-1 Cells
To determine if the induction of PAK1 phosphorylation is mediated by heparin via CD44-v3 in TCL-1 cells, Western blot analysis was used to examine the effects of an anti-CD44-v3 function-blocking antibody on the induction of heparininduced PAK1 phosphorylation. In the presence of the polyclonal anti-CD44-v3 function-blocking antibody, heparin-induced PAK1 phosphorylation at Thr423 was significantly inhibited (Fig. 6d ) compared to that in cells exposed to a control, nonimmune rabbit IgG (Fig. 6c) , although PAK1 phosphorylation at Ser199/204 was not inhibited (Fig. 6d ) compared to controls (Fig. 6d) . In the absence of heparin, only background levels of phosphorylation were detected with either the polyclonal anti-CD44-v3 blocking antibody or nonimmune rabbit IgG.
PI3K Inhibitor (KY12420) Suppresses Heparin-Enhanced Wound Closure in TCL-1 Cells
The PI3K inhibitor KY12420 was used to examine the effect of PAK1 phosphorylation on scratch wound closure in TCL-1 cells. PI3K inhibitor was used at a final concentration of 4 nM, which has been shown to effectively inhibit PAK1 phosphorylation, because it is a downstream target of PI3K. In the presence of heparin, PI3K inhibitor delayed scratch wound closure in TCL-1 cells, although it had no effect in the absence of heparin (Fig. 7) .
DISCUSSION
The present results suggest that heparin/HS/CD44-v3-mediated processes signal through the PAK1 pathway, which has been linked to CDC42 and RAC-mediated [25] cytoskeletal changes [26] in the absence of growth factor networks. We further show that the heparin/HS/CD44-v3 pathway enhances the migration of immortalized trophoblast cells derived from term human placenta in an in vitro scratch assay [23] .
We first demonstrate that heparin/HS enhances the closure of wounds made by mechanically scratching a monolayer of immortalized trophoblast cells that express cytokeratin 7 and CD9 on the cell surface when cultured under serum-free conditions. Heparin/HS is known to bind the receptor syndecan to initiate signal transduction [27] ; the lack of syndecan in TCL-1 cells, however, led us to examine the expression of another potential heparin/HS receptor, CD44-v3, in TCL-1 cells. In the present study, we confirmed that CD44-v3 is expressed in TCL-1 cells, similar to the expression in normal placenta. In TCL-1 cells cultured in serum-free media, knockdown of CD44 with siRNA targeting human CD44, as well as the blockage of heparin/HS binding to CD44 with a HEPARIN/CD44-v3 ENHANCES TROPHOBLAST MIGRATION polyclonal antibody against CD44, resulted in the suppression of cell migration into scratch wounds in the presence of heparin. These in vitro data indicate that the enhanced migration of TCL-1 cells by heparin in scratch assays is dependent on CD44.
We have observed that heparin/HS, which binds to CD44-v3, induces phosphorylation of PAK1 in scratched TCL-1 cells under serum-free conditions. Heparin-induced phosphorylation of PAK1 at Thr423 in TCL-1 cells was significantly inhibited by the addition of a polyclonal antibody against CD44-v3. The suppression of the normal migratory response of TCL-1 cells to scratch wounding and/or heparin treatment by PI3K inhibition indirectly suggests that PAK1 activation may be functionally required for migration, because PAK1 has been shown to be a downstream effector of PI3K signaling during the induction of cytoskeletal changes [28] . These observations suggest that PAK1 activation through the binding of heparin/HS to CD44-v3 may play an important role in the migration of trophoblast cells following the disruption of their monolayer structure.
Previous in vitro experiments have demonstrated that the invasion of trophoblast cells into the inner myometrial portion of the spiral arteries is regulated by a complex process that includes the loss of cell adhesion, cell migration, and digestion of matrix proteins, and fractionated heparin has been shown to suppress this invasion of first-trimester EVT cells [13] . Contradictory to this, heparin has also been shown to increase cellular invasion of first-trimester EVT cells [12] . The observed discrepancy in these in vitro studies likely can be attributed to the complexity of the multi-invasion process. Heparin/HS is also known to mediate the invasion process in various tumor cells [29] through several signaling pathways; this involves the anchoring of HSPG to CD44 and syndecan with cosignaling through the EGF and FGF receptors [16] . Thus, CD44-v3-mediated signaling combined with cosignaling through growth factors and their receptors may regulate the complex behavior of EVT cell invasion in vitro.
In vivo, the epithelium of the placental villous tree is comprised of two layers, a stem cell layer of mononucleated cytotrophoblast cells and a highly differentiated, multinucleated syncytiotrophoblast layer. The transport and metabolic functions of the syncytiotrophoblast is maintained by continuous proliferative turnover of cytotrophoblast cells and subsequent syncytial fusion. The data presented here do not directly indicate that, in vivo, heparin/HS/CD44-v3 enhances the repair of the damaged syncytiotrophoblast layer in the intervillous space through the migration of syncytiotrophoblast cells or cytotrophoblast cells. However, the data do suggest the possibility that enhanced coverage of the injured cell layer may 
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lead to the maintenance of syncytiotrophoblast cell function through heparin/HS/CD44-v3-mediated processes. The abundance of HSPG in the extracellular matrix beneath the trophoblast cells suggests that this environment could provide cells with enough HSPG to enable binding with CD44. Coverage of the trophoblast layer by normal trophoblast cells within the intervillous space might be accompanied by a reduced production of hypoxia-and hypoperfusion-induced factors, such as placental sFLT1, which is derived from damaged trophoblast cells [5] . The mechanism by which the administration of heparin to patients with APS effectively contributes to the prevention of pregnancy loss remains unclear. The signaling mechanism we present here may explain, in part, the beneficial effects of heparin on successful pregnancy outcomes in addition to the antithrombotic effect on the hypercoagulable state of the intervillous space [10] . Further study is needed to examine the effect of heparin/HS during repair of damaged trophoblast cells and the subsequent suppressed production of soluble factors from trophoblast cells and underlying interstitial cells, which has been linked to the pathogenesis of PE in patients with APS.
In conclusion, the data presented here indicate that heparin/ HS/CD44-v3-mediated signaling, in the absence of growth HEPARIN/CD44-v3 ENHANCES TROPHOBLAST MIGRATION factor networks, enhances the direct repair of the damaged trophoblast layer through the migration of trophoblast cells. The present study also suggests that the renewal of cell coverage induced by heparin/HS might contribute to the maintenance of syncytiotrophoblast cell function, although future experiments are needed to confirm this hypothesis.
